Jiahui An
Research Subjects
Jiahui An has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Genglin Guo
Shandong Institute of Sericulture, Shandong Academy of Agricultural Sciences, Yantai, China
2 shared publications Pei Li
College of Veterinary Medicine, Nanjing Agricultural University
2 shared publicationsQuan Li
College of Veterinary Medicine, Yangzhou University
2 shared publications- Wei Zhang
College of Veterinary Medicine, Nanjing Agricultural University
2 shared publications - Yufeng Li
Key Laboratory of Bacteriology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China
2 shared publications Chao Zhang
Key Laboratory of Bacteriology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China
1 shared publication
Latest Publications
- Open Access
- 23 September 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (9)
The truncated major pilin subunit SBP2’ contributes to Streptococcus suis meningitis by interacting with host plasminogen
Meningitis is one of the most striking manifestations of Streptococcus suis infection. Although multiple virulence-associated factors have been identified, the mechanisms underlying meningitis development remain incompletely understood. In S. suis , a srtBCD pilus gene cluster has been identified; our previous study suggested its association with bacterial virulence. In this study, we investigated the role of the srtBCD cluster in S. suis pathogenesis and confirmed that SBP2’ was specifically localized on the bacterial surface and was found to be essential for full virulence in a murine infection model, whereas deletion of other minor subunits had minimal impact. Using brain microvascular endothelial cells (BMECs), microglia, and a BALB/c mouse model, we examined how SBP2’ promotes the development of S. suis meningitis. Our results show that SBP2’ enhances bacterial colonization of BMECs and recruits host plasminogen, facilitating extracellular matrix (ECM) degradation, and thereby promoting bacterial invasion. In addition, SBP2’ enables S. suis to evade microglial phagocytosis and improves its intracellular survival. Importantly, a monoclonal antibody targeting SBP2’ conferred significant immunoprotection in mice. Together, these findings identify SBP2’ as an important virulence factor and plasminogen-binding receptor that facilitates S. suis traversal of the blood-brain barrier. IMPORTANCE: Streptococcus suis is an important zoonotic bacterial pathogen that could lead to severe damage in the central nervous system, but the mechanism underlying the breakthrough of the blood-brain barrier is still unclear. Pili are commonly considered virulence factors and subunit vaccine candidates, but no pilus structure could be observed on the surface of S. suis serotype 2. In this study, we found that the srtBCD pilus cluster, which was considered a pseudogene because of the truncation of the major pilus subunit, could be expressed, and the truncated major pilus subunit could be detected on the cell surface and be involved in the pathogenesis of S. suis serotype 2. Notably, monoclonal antibodies targeting SBP2’ provide immunoprotection in mice, reducing bacterial loads and brain damage. These findings identify SBP2’ as a key virulence factor and therapeutic target, offering insights into S. suis meningitis mechanisms.
- 23 September 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (9)
Open AccessThe truncated major pilin subunit SBP2’ contributes to Streptococcus suis meningitis by interacting with host plasminogen
Meningitis is one of the most striking manifestations of Streptococcus suis infection. Although multiple virulence-associated factors have been identified, the mechanisms underlying meningitis development remain incompletely understood. In S. suis , a srtBCD pilus gene cluster has been identified; our previous study suggested its association with bacterial virulence. In this study, we investigated the role of the srtBCD cluster in S. suis pathogenesis and confirmed that SBP2’ was specifically localized on the bacterial surface and was found to be essential for full virulence in a murine infection model, whereas deletion of other minor subunits had minimal impact. Using brain microvascular endothelial cells (BMECs), microglia, and a BALB/c mouse model, we examined how SBP2’ promotes the development of S. suis meningitis. Our results show that SBP2’ enhances bacterial colonization of BMECs and recruits host plasminogen, facilitating extracellular matrix (ECM) degradation, and thereby promoting bacterial invasion. In addition, SBP2’ enables S. suis to evade microglial phagocytosis and improves its intracellular survival. Importantly, a monoclonal antibody targeting SBP2’ conferred significant immunoprotection in mice. Together, these findings identify SBP2’ as an important virulence factor and plasminogen-binding receptor that facilitates S. suis traversal of the blood-brain barrier. IMPORTANCE: Streptococcus suis is an important zoonotic bacterial pathogen that could lead to severe damage in the central nervous system, but the mechanism underlying the breakthrough of the blood-brain barrier is still unclear. Pili are commonly considered virulence factors and subunit vaccine candidates, but no pilus structure could be observed on the surface of S. suis serotype 2. In this study, we found that the srtBCD pilus cluster, which was considered a pseudogene because of the truncation of the major pilus subunit, could be expressed, and the truncated major pilus subunit could be detected on the cell surface and be involved in the pathogenesis of S. suis serotype 2. Notably, monoclonal antibodies targeting SBP2’ provide immunoprotection in mice, reducing bacterial loads and brain damage. These findings identify SBP2’ as a key virulence factor and therapeutic target, offering insights into S. suis meningitis mechanisms.
- 5 January 2026
- Published by Springer Nature in Folia Microbiologica
- p. 1-11
Class C sortases of the SrtBCD pilus cluster involved in the virulence of Streptococcus suis in the mouse model
- 5 January 2026
- Published by Springer Nature in Folia Microbiologica
- p. 1-11
Class C sortases of the SrtBCD pilus cluster involved in the virulence of Streptococcus suis in the mouse model
- 18 June 2024
- Published by Elsevier in Aquaculture
- Vol. 593
Development of an in silico serotyping database of Vibrio harveyi by identification and comparison of O-antigen encoding loci
- 18 June 2024
- Published by Elsevier in Aquaculture
- Vol. 593
Development of an in silico serotyping database of Vibrio harveyi by identification and comparison of O-antigen encoding loci
- Open Access
Floxed Il1rl2 Locus with mCherry Reporter Element Reveals Distinct Expression Patterns of the IL-36 Receptor in Barrier Tissues
IL-36 cytokines are emerging as beneficial in immunity against pathogens and cancers but can also be detrimental when dysregulated in autoimmune and autoinflammatory conditions. Interest in targeting IL-36 activity for therapeutic purposes is rapidly growing, yet many unknowns about the functions of these cytokines remain. Thus, the availability of robust research tools is essential for both fundamental basic science and pre-clinical studies to fully access outcomes of any manipulation of the system. For this purpose, a floxed Il1rl2, the gene encoding the IL-36 receptor, mouse strain was developed to facilitate the generation of conditional knockout mice. The targeted locus was engineered to contain an inverted mCherry reporter sequence that upon Cre-mediated recombination will be flipped and expressed under the control of the endogenous Il1rl2 promoter. This feature can be used to confirm knockout in individual cells but also as a reporter to determine which cells express the IL-36 receptor IL-1RL2. The locus was confirmed to function as intended and further used to demonstrate the expression of IL-1RL2 in barrier tissues. Il1rl2 expression was detected in leukocytes in all barrier tissues. Interestingly, strong expression was observed in epithelial cells at locations in direct contact with the environment such as the skin, oral mucosa, the esophagus, and the upper airways, but almost absent from epithelial cells at more inward facing sites, including lung alveoli, the small intestine, and the colon. These findings suggest specialized functions of IL-1RL2 in outward facing epithelial tissues and cells. The generated mouse model should prove valuable in defining such functions and may also facilitate basic and translational research.
Open AccessFloxed Il1rl2 Locus with mCherry Reporter Element Reveals Distinct Expression Patterns of the IL-36 Receptor in Barrier Tissues
IL-36 cytokines are emerging as beneficial in immunity against pathogens and cancers but can also be detrimental when dysregulated in autoimmune and autoinflammatory conditions. Interest in targeting IL-36 activity for therapeutic purposes is rapidly growing, yet many unknowns about the functions of these cytokines remain. Thus, the availability of robust research tools is essential for both fundamental basic science and pre-clinical studies to fully access outcomes of any manipulation of the system. For this purpose, a floxed Il1rl2, the gene encoding the IL-36 receptor, mouse strain was developed to facilitate the generation of conditional knockout mice. The targeted locus was engineered to contain an inverted mCherry reporter sequence that upon Cre-mediated recombination will be flipped and expressed under the control of the endogenous Il1rl2 promoter. This feature can be used to confirm knockout in individual cells but also as a reporter to determine which cells express the IL-36 receptor IL-1RL2. The locus was confirmed to function as intended and further used to demonstrate the expression of IL-1RL2 in barrier tissues. Il1rl2 expression was detected in leukocytes in all barrier tissues. Interestingly, strong expression was observed in epithelial cells at locations in direct contact with the environment such as the skin, oral mucosa, the esophagus, and the upper airways, but almost absent from epithelial cells at more inward facing sites, including lung alveoli, the small intestine, and the colon. These findings suggest specialized functions of IL-1RL2 in outward facing epithelial tissues and cells. The generated mouse model should prove valuable in defining such functions and may also facilitate basic and translational research.
- RetractionOpen Access
- 5 April 2023
- Published by Elsevier in Molecular Therapy
- Vol. 31 (5) , 1496
Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically
- 5 April 2023
- Published by Elsevier in Molecular Therapy
- Vol. 31 (5) , 1496
RetractionOpen AccessRetraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically
- Open Access
- 16 November 2022
- Published by Wiley in Cellular Microbiology
- Vol. 2022, 1-10
Severe Inflammation Caused by Coinfection of PCV2 and Glaesserella parasuis Is Associated with Pyroptosis via Noncanonical Inflammasome Pathway
Coinfections of porcine circovirus type 2 (PCV2) and Glaesserella parasuis (G. parasuis) are widely existing in the swine industry worldwide. However, the mechanisms for this coinfection remain unclear. The aim of this study is to assess whether the coinfection PCV2 and G. parasuis would affect the inflammatory response and related mechanisms. In this study, BALB/c mice and RAW264.7 cells were used to study the inflammation and related mechanism caused by the coinfection of PCV2 and G. parasuis. Coinfection with PCV2 and G. parasuis significantly increased the mortality of mice and led to the development of more severe lung and spleen lesions compared with single agent infection. Especially, coinfection significantly increased the bacterial loads in the lungs. Coinfection with PCV2 and G. parasuis can enhance RAW264.7 cell phagocytosis and elimination to G. parasuis. Cell death rate of cells increased in coinfection was measured with Flow cytometry. Moreover, coinfection led to the downregulation of the expression of TNFα and IL-8 in comparison with G. parasuis infection, but the maturation of interleukin-1β (IL-1β) was significantly upregulated. Our study firstly revealed that coinfection of PCV2 and G. parasuis can increase the phagocytosis of cells to G. parasuis, and LPS in the cytoplasm will induce the maturation of caspase-11 and lead to the cleavage of Gasdermin D (GSDMD) to cause pyroptosis by noncanonical pathway. The revealing of mechanisms associated with coinfection with PCV2 and G. parasuis will provide a scientific basis for investigating the synergistic infection mechanisms between viruses and bacteria.
- 16 November 2022
- Published by Wiley in Cellular Microbiology
- Vol. 2022, 1-10
Open AccessSevere Inflammation Caused by Coinfection of PCV2 and Glaesserella parasuis Is Associated with Pyroptosis via Noncanonical Inflammasome Pathway
Coinfections of porcine circovirus type 2 (PCV2) and Glaesserella parasuis (G. parasuis) are widely existing in the swine industry worldwide. However, the mechanisms for this coinfection remain unclear. The aim of this study is to assess whether the coinfection PCV2 and G. parasuis would affect the inflammatory response and related mechanisms. In this study, BALB/c mice and RAW264.7 cells were used to study the inflammation and related mechanism caused by the coinfection of PCV2 and G. parasuis. Coinfection with PCV2 and G. parasuis significantly increased the mortality of mice and led to the development of more severe lung and spleen lesions compared with single agent infection. Especially, coinfection significantly increased the bacterial loads in the lungs. Coinfection with PCV2 and G. parasuis can enhance RAW264.7 cell phagocytosis and elimination to G. parasuis. Cell death rate of cells increased in coinfection was measured with Flow cytometry. Moreover, coinfection led to the downregulation of the expression of TNFα and IL-8 in comparison with G. parasuis infection, but the maturation of interleukin-1β (IL-1β) was significantly upregulated. Our study firstly revealed that coinfection of PCV2 and G. parasuis can increase the phagocytosis of cells to G. parasuis, and LPS in the cytoplasm will induce the maturation of caspase-11 and lead to the cleavage of Gasdermin D (GSDMD) to cause pyroptosis by noncanonical pathway. The revealing of mechanisms associated with coinfection with PCV2 and G. parasuis will provide a scientific basis for investigating the synergistic infection mechanisms between viruses and bacteria.
- Open Access
- 5 July 2021
- Published by Springer Nature in Veterinary Research
- Vol. 52 (1) , 1-10
Characterization and protective activity of monoclonal antibodies directed against Fe (3+) ABC transporter substrate-binding protein of Glaesserella parasuis
Glässer’s disease is caused by the agent Glaesserella parasuis and is difficult to prevent and control. Candidate screening for subunit vaccines contributes to the prevention of this disease. Therefore, in this study, the inactivated G. parasuis reference serovar 5 strain (G. parasuis-5) was used to generate specific monoclonal antibodies (mAbs) to screen subunit vaccine candidates. Six mAbs (1A12, 3E3, 4C6, 2D1, 3E6, and 4B2) were screened, and they all reacted with the G. parasuis serovar 5 strain according to laser confocal microscopy and flow cytometry (FCM). Indirect enzyme-linked immunosorbent assay (ELISA) showed that one mAb 2D1, can react with all 15 reference serovars of G. parasuis. Protein mass spectrometry and Western blot analysis demonstrated that mAb 2D1 specifically reacts with Fe (3+) ABC transporter substrate-binding protein. A complement killing assay found that the colony numbers of bacteria were significantly reduced in the G. parasuis-5 group incubated with mAb 2D1 (p < 0.01) in comparison with the control group. Opsonophagocytic assays demonstrated that mAb 2D1 significantly enhanced the phagocytosis of 3D4/21 cells by G. parasuis (p < 0.05). RAW264.7 cells with stronger phagocytic ability were also used for the opsonophagocytic assay, and the difference was highly significant (p < 0.01). Passive immunization of mice revealed that mAb 2D1 can eliminate the bacteria in the blood and provide protection against G. parasuis-5. Our study found one mAb that can be used to prevent and control G. parasuis infection in vivo and in vitro, which may suggest that Fe (3+) ABC transporter substrate-binding protein is an immunodominant antigen and a promising candidate for subunit vaccine development.
- 5 July 2021
- Published by Springer Nature in Veterinary Research
- Vol. 52 (1) , 1-10
Open AccessCharacterization and protective activity of monoclonal antibodies directed against Fe (3+) ABC transporter substrate-binding protein of Glaesserella parasuis
Glässer’s disease is caused by the agent Glaesserella parasuis and is difficult to prevent and control. Candidate screening for subunit vaccines contributes to the prevention of this disease. Therefore, in this study, the inactivated G. parasuis reference serovar 5 strain (G. parasuis-5) was used to generate specific monoclonal antibodies (mAbs) to screen subunit vaccine candidates. Six mAbs (1A12, 3E3, 4C6, 2D1, 3E6, and 4B2) were screened, and they all reacted with the G. parasuis serovar 5 strain according to laser confocal microscopy and flow cytometry (FCM). Indirect enzyme-linked immunosorbent assay (ELISA) showed that one mAb 2D1, can react with all 15 reference serovars of G. parasuis. Protein mass spectrometry and Western blot analysis demonstrated that mAb 2D1 specifically reacts with Fe (3+) ABC transporter substrate-binding protein. A complement killing assay found that the colony numbers of bacteria were significantly reduced in the G. parasuis-5 group incubated with mAb 2D1 (p < 0.01) in comparison with the control group. Opsonophagocytic assays demonstrated that mAb 2D1 significantly enhanced the phagocytosis of 3D4/21 cells by G. parasuis (p < 0.05). RAW264.7 cells with stronger phagocytic ability were also used for the opsonophagocytic assay, and the difference was highly significant (p < 0.01). Passive immunization of mice revealed that mAb 2D1 can eliminate the bacteria in the blood and provide protection against G. parasuis-5. Our study found one mAb that can be used to prevent and control G. parasuis infection in vivo and in vitro, which may suggest that Fe (3+) ABC transporter substrate-binding protein is an immunodominant antigen and a promising candidate for subunit vaccine development.